Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Shyr

Showing results (401-410 of 435) with videos related to

Pageof 44
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2017
A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67Bojana Jovanović, Ingrid A Mayer, Erica L Mayer, et al.
Cancer|February 7, 2025
Olaparib in treatment-refractory isocitrate dehydrogenase 1 (IDH1)- and IDH2-mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 10129 trialMichael Cecchini, Mary Jo Pilat, Nataliya Uboha, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Genome sequencing of 35,024 predominantly African ancestry persons addresses gaps in genomics and healthcareCecile Avery, Mojgan Babanejad, James Baker, et al.
American Journal of Respiratory and Critical Care Medicine|January 9, 2023
The Genetic Landscape of Familial Pulmonary FibrosisQi Liu, Yuan Zhou, Joy D Cogan, et al.
Chest|June 20, 2020
Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019: Survival and Clinical OutcomesChristina C Price, Frederick L Altice, Yu Shyr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2017
The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2)Dara L Aisner, Lynette M Sholl, Lynne D Berry, et al.
Cancer Immunology Research|September 28, 2016
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 BlockadeDouglas B Johnson, Garrett M Frampton, Matthew J Rioth, et al.
JCI Insight|January 11, 2019
Human PAH is characterized by a pattern of lipid-related insulin resistanceAnna R Hemnes, J Matthew Luther, Christopher J Rhodes, et al.
Circulation|August 30, 2025
Ivabradine in Patients Undergoing Noncardiac Surgery: a Randomized Controlled TrialWojciech Szczeklik, Jakub Fronczek, Zbigniew Putowski, et al.
The Journal of Clinical Investigation|September 23, 2014
DC isoketal-modified proteins activate T cells and promote hypertensionAnnet Kirabo, Vanessa Fontana, Ana P C de Faria, et al.
Pageof 44

Showing results (401-410 of 435) with videos related to

Sort By:
Pageof 44
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2017
A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67Bojana Jovanović, Ingrid A Mayer, Erica L Mayer, et al.
Cancer|February 7, 2025
Olaparib in treatment-refractory isocitrate dehydrogenase 1 (IDH1)- and IDH2-mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 10129 trialMichael Cecchini, Mary Jo Pilat, Nataliya Uboha, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Genome sequencing of 35,024 predominantly African ancestry persons addresses gaps in genomics and healthcareCecile Avery, Mojgan Babanejad, James Baker, et al.
American Journal of Respiratory and Critical Care Medicine|January 9, 2023
The Genetic Landscape of Familial Pulmonary FibrosisQi Liu, Yuan Zhou, Joy D Cogan, et al.
Chest|June 20, 2020
Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019: Survival and Clinical OutcomesChristina C Price, Frederick L Altice, Yu Shyr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2017
The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2)Dara L Aisner, Lynette M Sholl, Lynne D Berry, et al.
Cancer Immunology Research|September 28, 2016
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 BlockadeDouglas B Johnson, Garrett M Frampton, Matthew J Rioth, et al.
JCI Insight|January 11, 2019
Human PAH is characterized by a pattern of lipid-related insulin resistanceAnna R Hemnes, J Matthew Luther, Christopher J Rhodes, et al.
Circulation|August 30, 2025
Ivabradine in Patients Undergoing Noncardiac Surgery: a Randomized Controlled TrialWojciech Szczeklik, Jakub Fronczek, Zbigniew Putowski, et al.
The Journal of Clinical Investigation|September 23, 2014
DC isoketal-modified proteins activate T cells and promote hypertensionAnnet Kirabo, Vanessa Fontana, Ana P C de Faria, et al.
Pageof 44